Evidence map›Paper›PMID 29381948›Full record

ArticleMedicine2017

Primary extraskeletal myxoid chondrosarcoma in cerebellum: A case report with literature review.

You Qin, Hai-Bo Zhang, Chang-Shu Ke, Jing Huang, Bian Wu, Chao Wan, Chen-Su Yang, Kun-Yu Yang

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

You QinCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang People's Hospital of Hangzhou medical college, Hangzhou, Zhejiang Province Department of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Hai-Bo Zhang
Chang-Shu Ke
Jing Huang
Bian Wu
Chao Wan
Chen-Su Yang
Kun-Yu Yang
Huazhong University of Science and Technology · CNHangzhou Medical College · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleExtraskeletal myxoid chondrosarcoma (EMC) is a rare malignant neoplasm of which intracranial EMC is the rarest. PATIENT CONCERNS: We present an unusual case report of a 41-year-old woman who was sent to the emergency department for a sudden headache and other symptoms related to increased intracranial pressure.

interventionsEmergent CT revealed an occupying lesion in the left cerebellum with surrounding edema. A complete surgical excision of the lesion through a transcortical approach was performed. After the operation, this patient received adjuvant radiotherapy and temozolomide treatment. DIAGNOSES: Pathology diagnosis was an intracranial EMC. OUTCOMES: The patient survives with no tumor recurrence as of the last follow-up. Progression-free survival exceeded 20 months. LESSONS: We have reviewed the literature and here summarize the diagnosis and treatment options for intracranial EMC. Diagnosis and treatment options of this rare disease are discussed.

Indexed as

Cerebellar NeoplasmsCerebellumChondrosarcomaNeoplasms, Connective and Soft TissueAdultAntineoplastic Agents, AlkylatingChemoradiotherapy, AdjuvantDacarbazineFemaleHumansIntracranial HypertensionNeurosurgical ProceduresTemozolomideTomography, X-Ray ComputedTreatment OutcomeAntineoplastic Agents, AlkylatingDacarbazineTemozolomide

Identifiers

PMID29381948
PMCPMC5708947
OpenAlexW2769566561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.